To mark the end of the week in which World Tuberculosis Day was observed, the work carried out by GHTM | Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa (IHMT NOVA) stands out not only for its scientific relevance but also for its strong commitment to national and international collaboration.
GHTM R&D Unit is part of an extensive network of partners that includes academic institutions, hospitals, public health institutes, and specialised tuberculosis laboratories across Europe, Africa, and South America. In Portugal, this collaboration involves institutions such as the Research Institute for Medicines (iMed.ULisboa), University of Lisbon, the Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), Hospital Curry Cabral – Unidade Local de Saúde de São José, the Escola Nacional de Saúde Pública (ENSP), Universidade NOVA de Lisboa, and the Fundação Calouste Gulbenkian.
Internationally, GHTM works closely with leading institutions such as the London School of Hygiene & Tropical Medicine (LSHTM) and the University of Oxford in the United Kingdom, the Institut Pasteur and Université de Paris in France, the University of Parma in Italy, and the Saint Petersburg Pasteur Institute in Russia. In South America, key collaborations include the Universidade Federal do Rio Grande do Sul and the Fundação Estadual de Produção e Pesquisa em Saúde in Brazil, while in Africa, partnerships with hospitals and TB laboratories in Guinea-Bissau and Angola further strengthen the global reach of this network.
These partnerships are reinforced through participation in international scientific networks such as European Committee on Antimicrobial Susceptibility Testing – EUCAST, with a key role in the diagnosis and study of antimycobacterial drug resistance, TB Alliance, dedicated to the development of better, faster-acting, and affordable tuberculosis treatments, and REDE-TB, focused on advancing new tools and strategies for TB control.
Through joint publications, shared laboratory expertise, and collaborative research projects, this network supports advances in molecular epidemiology, antimicrobial resistance, drug discovery, and clinical management of tuberculosis. To date, GHTM has contributed to 408 scientific publications in the field of tuberculosis, reflecting the impact and consistency of its research efforts.
Overall, GHTM | IHMT NOVA brings together a research network of around 70 collaborators worldwide — including 20 in Portugal, 13 in Brazil, 13 in African Portuguese-speaking countries, 10 across Europe, and 14 in other international research units — reflecting a truly global approach to tackling tuberculosis.
